|

Post-market Evaluation of LumiSystem: Intraoperative Margin Performance and Clinical Utility (IMPACT) Registry

RECRUITINGSponsored by Lumicell, Inc.
Actively Recruiting
SponsorLumicell, Inc.
Started2026-09-30
Est. completion2030-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations2 sites

Summary

This is a minimal risk post-market registry study conducted at participating clinical institutions that are utilizing LumiSystem consistent with the U.S. Food and Drug Administration (FDA) approved indication for use to collect data on the use of LumiSystem in a real-world setting to support the evaluation of safety, effectiveness, clinical utility (including impact to healthcare utilization and surgical management), and product and quality improvements.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Participant must be consistent with FDA approved indication

Exclusion Criteria:

* Participant is enrolled in a clinical trial using an investigational product directing tissue removal during the lumpectomy procedure

Conditions2

Breast CancerCancer

Locations2 sites

Alabama

1 site
University of South Alabama Health
Mobile, Alabama, 36604
Tiffany Hill251-445-3276tnfulford@health.southalabama.edu

California

1 site
Stanford University
Palo Alto, California, 94304
Trudy Sea-Eun Kim(650) 498-1106trudykim@stanford.edu

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.